Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 065032
Company: SANDOZ INC
Company: SANDOZ INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DOXYCYCLINE | DOXYCYCLINE | EQ 50MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
| DOXYCYCLINE | DOXYCYCLINE | EQ 100MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/30/2000 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/65032ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/23/2002 | SUPPL-2 | Labeling |
Label is not available on this site. |
||
| 12/07/2000 | SUPPL-1 | Manufacturing (CMC)-Control |
Label is not available on this site. |